Financial Summary (All financials)
In millions, except per share items | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 |
Revenues | 1,837.4 | 1,420.3 | 1,197.2 | 1,215.4 |
Revenue growth | 29.4% | 18.6% | -1.5% | |
Cost of goods sold | 985.1 | 781.4 | 663.7 | 583.6 |
Gross profit | 852.3 | 639.0 | 533.5 | 631.8 |
Gross margin | 46.4% | 45.0% | 44.6% | 52.0% |
Sales and marketing | 272.6 | 212.2 | 169.0 | 143.6 |
Research and development | 141.6 | 108.3 | 76.0 | 88.0 |
General and administrative | 162.4 | 122.4 | 118.4 | 110.5 |
EBITA | 275.7 | 196.0 | 170.1 | 289.7 |
EBITA margin | 15.0% | 13.8% | 14.2% | 23.8% |
Amortization of intangibles | 22.5 | 19.7 | 16.2 | 19.4 |
EBIT | 253.2 | 176.3 | 154.0 | 270.3 |
EBIT margin | 13.8% | 12.4% | 12.9% | 22.2% |
Pre-tax income | 221.8 | 144.4 | 169.5 | 297.0 |
Income taxes | 23.8 | 45.6 | 51.7 | 54.1 |
Tax rate | 10.7% | 31.5% | 30.5% | 18.2% |
Earnings from continuing ops | 198.0 | 99.0 | 118.6 | 243.3 |
Earnings from discontinued ops | | 22.2 | | |
Net income | 198.0 | 121.3 | 122.8 | 243.3 |
Net margin | 10.8% | 8.5% | 10.3% | 20.0% |
|
Diluted EPS | $0.74 | $0.40 | $0.48 | $1.19 |
Shares outstanding (diluted) | 268.8 | 248.6 | 246.7 | 204.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|